Rubric Capital Management (New York)’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,844
| Closed | -$30.7K | – | 80 |
|
|
2024
Q4 | $30.7K | Hold |
5,844
| – | – | ﹤0.01% | 67 |
|
|
2024
Q3 | $83.7K | Hold |
5,844
| – | – | ﹤0.01% | 64 |
|
|
2024
Q2 | $94.7K | Hold |
5,844
| – | – | ﹤0.01% | 67 |
|
|
2024
Q1 | $591K | Sell |
5,844
-11,875
| -67% | -$1.2M | 0.02% | 68 |
|
|
2023
Q4 | $418K | Hold |
17,719
| – | – | 0.01% | 56 |
|
|
2023
Q3 | $358K | Hold |
17,719
| – | – | 0.01% | 59 |
|
|
2023
Q2 | $461K | Sell |
17,719
-1,617
| -8% | -$42K | 0.02% | 60 |
|
|
2023
Q1 | $402K | Hold |
19,336
| – | – | 0.01% | 70 |
|
|
2022
Q4 | $394K | Sell |
19,336
-86,014
| -82% | -$1.75M | 0.02% | 94 |
|
|
2022
Q3 | $2.91M | Hold |
105,350
| – | – | 0.15% | 74 |
|
|
2022
Q2 | $2.78M | Hold |
105,350
| – | – | 0.15% | 74 |
|
|
2022
Q1 | $8.43M | Buy |
105,350
+26,038
| +33% | +$2.08M | 0.3% | 49 |
|
|
2021
Q4 | $16.2M | Buy |
79,312
+13,692
| +21% | +$2.79M | 0.76% | 38 |
|
|
2021
Q3 | $21.2M | Buy |
65,620
+38,937
| +146% | +$12.6M | 0.59% | 34 |
|
|
2021
Q2 | $6.93M | Buy |
+26,683
| New | +$6.93M | 0.44% | 44 |
|
|
2020
Q4 | – | Sell |
-995
| Closed | -$247K | – | 85 |
|
|
2020
Q3 | $247K | Buy |
+995
| New | +$247K | 0.02% | 62 |
|